| Name | Title | Contact Details |
|---|
SC Distributors is focused on a simple, yet powerful mission: provide professional financial advisors and their investors with access to select alternative investment products. Our approach to designing products and providing financial solutions begins and ends with a commitment to thoroughly research and analyze what we believe are the best available product sponsors and investment strategies. Our leadership`s extensive experience in wholesale distribution, combined with our strategy to engage a prominent real estate investment banking organization, helps enable us to identify and evaluate the capabilities, backgrounds, financial sustainability and track records of a wide variety of potential investment managers. Finally, our leadership`s extensive distribution experience and our proprietary SCORE (Strategic Capital Online Reporting Engine) technology platform helps us to effectively and efficiently track and manage each step of the product delivery process for our financial advisor and broker/dealer partners.
WR Hambrecht Co. is a San Francisco, CA-based company in the Financial Services sector.
Sofos Capital is a Miami, FL-based company in the Financial Services sector.
Harris and Harris Group, Inc. builds transformative companies from disruptive science. We leverage our core scientific expertise to be FIRST in identifying new technology trends, in accessing high quality science and intellectual property, in building management teams and in executing on early-stage business growth. Our PROVEN team has the unique ability to identify and diligence the network of discoveries that come from understanding science at the intersection of different scientific disciplines, with biology as a focus. This places us at the center of the discoveries impacting some of the most important growth sectors of the economy, permitting us to build TRANSFORMATIVE companies. BIOLOGY+ is our distinctive approach. We define BIOLOGY+ as investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics, physics, materials science, chemistry, information technology, engineering and mathematics. We focus on this intersection because we believe interdisciplinary innovation will be required in order to address many of the life science challenges of the future.
Trilantic Capital Partners is a global private equity firm focused on control and significant minority investments in North America and Europe managed by Trilantic North America and Trilantic Europe. We employ flexible transaction structures and have a strong heritage of partnering with family-owned businesses and providing growth capital to outstanding management teams. We primarily target investments in the consumer, energy, industrials, TMT, healthcare, financial and business services sectors, and currently manage six private equity funds.